Corbus Pharmaceuticals Holdings
Q1 2020 13F Holders
Symbol
CRBP
CUSIP
21833P301
Type
Equity
Class
COM NEW
Num filings
1
Total reported value, excl. options
$5.24 k
Compare 2020 Q1 to
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
2019 Q4
Manager
Report Date
Value ($000)
Shares
Option Type